These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 27524655)

  • 1. Mapping the effect of escitalopram treatment on amplitude of low-frequency fluctuations in patients with depression: a resting-state fMRI study.
    Wang L; Li X; Li K; Su Y; Zeng Y; Zhang Q; Wang G; Jin Z; Kong Q; Si T
    Metab Brain Dis; 2017 Feb; 32(1):147-154. PubMed ID: 27524655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of antidepressant treatment on resting-state functional brain networks in patients with major depressive disorder.
    Wang L; Xia M; Li K; Zeng Y; Su Y; Dai W; Zhang Q; Jin Z; Mitchell PB; Yu X; He Y; Si T
    Hum Brain Mapp; 2015 Feb; 36(2):768-78. PubMed ID: 25332057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term effects of escitalopram on regional brain function in first-episode drug-naive patients with major depressive disorder assessed by resting-state functional magnetic resonance imaging.
    Wang L; Li K; Zhang Q; Zeng Y; Dai W; Su Y; Wang G; Tan Y; Jin Z; Yu X; Si T
    Psychol Med; 2014 May; 44(7):1417-26. PubMed ID: 23942213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of antidepressant treatment on long-range and short-range functional connectivity strength in patients with major depressive disorder.
    An J; Wang L; Li K; Zeng Y; Su Y; Jin Z; Yu X; Si T
    Sci Rep; 2017 Aug; 7(1):10214. PubMed ID: 28860564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partly recovery and compensation in anterior cingulate cortex after SSRI treatment-evidence from multi-voxel pattern analysis over resting state fMRI in depression.
    Zhang Y; Shao J; Wang X; Pei C; Zhang S; Yao Z; Lu Q
    J Affect Disord; 2023 Jan; 320():404-412. PubMed ID: 36179779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resting-state brain alteration after a single dose of SSRI administration predicts 8-week remission of patients with major depressive disorder.
    Cheng Y; Xu J; Arnone D; Nie B; Yu H; Jiang H; Bai Y; Luo C; Campbell RA; Shan B; Xu L; Xu X
    Psychol Med; 2017 Feb; 47(3):438-450. PubMed ID: 27697079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of 12-week escitalopram treatment on resting-state functional connectivity of large-scale brain networks in major depressive disorder.
    Zhang S; Zhou J; Cui J; Zhang Z; Liu R; Feng Y; Feng L; Wang Y; Chen X; Wu H; Jin Y; Zhou Y; Wang G
    Hum Brain Mapp; 2023 Apr; 44(6):2572-2584. PubMed ID: 36773284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of thalamic hyperactivity with treatment-resistant depression and poor response in early treatment for major depression: a resting-state fMRI study using fractional amplitude of low-frequency fluctuations.
    Yamamura T; Okamoto Y; Okada G; Takaishi Y; Takamura M; Mantani A; Kurata A; Otagaki Y; Yamashita H; Yamawaki S
    Transl Psychiatry; 2016 Mar; 6(3):e754. PubMed ID: 26954981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence and interaction of resting state functional magnetic resonance and tryptophan hydroxylase-2 methylation on short-term antidepressant drug response.
    Tan T; Xu Z; Gao C; Shen T; Li L; Chen Z; Chen L; Xu M; Chen B; Liu J; Zhang Z; Yuan Y
    BMC Psychiatry; 2022 Mar; 22(1):218. PubMed ID: 35337298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. fMRI response to negative words and SSRI treatment outcome in major depressive disorder: a preliminary study.
    Miller JM; Schneck N; Siegle GJ; Chen Y; Ogden RT; Kikuchi T; Oquendo MA; Mann JJ; Parsey RV
    Psychiatry Res; 2013 Dec; 214(3):296-305. PubMed ID: 24446548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in patients with major depressive disorder before and after electroconvulsive therapy measured by fractional amplitude of low-frequency fluctuations (fALFF).
    Qiu H; Li X; Luo Q; Li Y; Zhou X; Cao H; Zhong Y; Sun M
    J Affect Disord; 2019 Feb; 244():92-99. PubMed ID: 30326347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multimodal functional and structural neuroimaging investigation of major depressive disorder following treatment with duloxetine.
    Fu CH; Costafreda SG; Sankar A; Adams TM; Rasenick MM; Liu P; Donati R; Maglanoc LA; Horton P; Marangell LB
    BMC Psychiatry; 2015 Apr; 15():82. PubMed ID: 25880400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Difference in amplitude of low-frequency fluctuation between currently depressed and remitted females with major depressive disorder.
    Jing B; Liu CH; Ma X; Yan HG; Zhuo ZZ; Zhang Y; Wang SH; Li HY; Wang CY
    Brain Res; 2013 Dec; 1540():74-83. PubMed ID: 24121137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A genome-wide association study of escitalopram treatment outcomes in patients with major depressive disorder.
    Ren S; Peng H; Zhang J; Yang J; He Y; Sun Z; Wang G
    Gene; 2024 Oct; 926():148596. PubMed ID: 38782219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eight-week antidepressant treatment reduces functional connectivity in first-episode drug-naïve patients with major depressive disorder.
    Li L; Su YA; Wu YK; Castellanos FX; Li K; Li JT; Si TM; Yan CG
    Hum Brain Mapp; 2021 Jun; 42(8):2593-2605. PubMed ID: 33638263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resting-state brain activation correlates with short-time antidepressant treatment outcome in drug-naïve patients with major depressive disorder.
    Wang LJ; Kuang WH; Xu JJ; Lei D; Yang YC
    J Int Med Res; 2014 Aug; 42(4):966-75. PubMed ID: 24898399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fronto-limbic effective connectivity as possible predictor of antidepressant response to SSRI administration.
    Vai B; Bulgarelli C; Godlewska BR; Cowen PJ; Benedetti F; Harmer CJ
    Eur Neuropsychopharmacol; 2016 Dec; 26(12):2000-2010. PubMed ID: 27756525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duloxetine effects on striatal resting-state functional connectivity in patients with major depressive disorder.
    Wang L; An J; Gao HM; Zhang P; Chen C; Li K; Mitchell PB; Si TM
    Hum Brain Mapp; 2019 Aug; 40(11):3338-3346. PubMed ID: 31066977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Escitalopram : a review of its use in the management of major depressive and anxiety disorders.
    Waugh J; Goa KL
    CNS Drugs; 2003; 17(5):343-62. PubMed ID: 12665392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Escitalopram but not placebo modulates brain rhythmic oscillatory activity in the first week of treatment of Major Depressive Disorder.
    Leuchter AF; Hunter AM; Jain FA; Tartter M; Crump C; Cook IA
    J Psychiatr Res; 2017 Jan; 84():174-183. PubMed ID: 27770740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.